# Coexistence of Adult-Onset Still's Disease and Graves' Disease: Coincidence or Continuum?

**Authors:** Inass Chaari, Ayoub Idrissi, Lahoussaine Abainou, Hamza El Jadi, Azzelarab Meftah, Hicham Baizri

PMC · DOI: 10.7759/cureus.100076 · Cureus · 2025-12-25

## TL;DR

This paper explores the rare coexistence of Adult-Onset Still's Disease and Graves' Disease, suggesting a possible shared immune mechanism.

## Contribution

The paper highlights a potential pathophysiological link between two rare autoimmune diseases through a case study and literature review.

## Key findings

- A 22-year-old patient exhibited both AOSD and GD, with overlapping immune dysregulation.
- Shared genetic susceptibility and cytokine involvement suggest a possible continuum between the two diseases.
- Systematic thyroid screening is recommended for AOSD patients to detect coexisting GD.

## Abstract

Adult-onset Still’s disease (AOSD) is a rare systemic autoimmune disorder of unclear etiology, typically characterized by prolonged fever, arthralgia, transient rash, and leukocytosis. Graves’ disease (GD) is a common autoimmune cause of hyperthyroidism in young adults. Although associations between autoimmune conditions have been reported, the coexistence of AOSD and GD remains uncommon.

We describe the case of a 22-year-old patient presenting with clinical and biochemical hyperthyroidism, confirmed by thyroid scintigraphy. The clinical picture was further complicated by persistent inflammatory syndrome, marked hyperferritinemia, and hepatosplenomegaly, consistent with AOSD as defined by Yamaguchi’s criteria. The disease course was characterized by recurrent inflammatory flares of both conditions and the development of carbimazole-induced hepatocellular injury, necessitating discontinuation of the drug and subsequent radioiodine ablation. The patient was also treated with corticosteroid therapy, leading to favorable clinical and laboratory improvement.

Several reports have documented the association between AOSD and GD, suggesting a potential shared pathophysiological basis. Both conditions exhibit genetic susceptibility linked to HLA-DRB1 alleles and share immune dysregulation driven by excessive cytokine production, particularly interleukin-18, tumor necrosis factor-α, and interferon-γ. This molecular overlap may account for their coexistence in some patients, regardless of sex.

Systematic screening for thyroid dysfunction is advisable in patients with AOSD, irrespective of gender, in order to better identify this underrecognized association.

## Linked entities

- **Genes:** HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) [NCBI Gene 3123]
- **Proteins:** IL18 (interleukin 18)
- **Chemicals:** carbimazole (PubChem CID 31072)
- **Diseases:** Adult-onset Still's disease (MONDO:0019355), Graves' disease (MONDO:0005364), hyperthyroidism (MONDO:0004425)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) [NCBI Gene 3123] {aka DRB1, HLA-DR1B, HLA-DRB, SS1}
- **Diseases:** inflammatory (MESH:D007249), fever (MESH:D005334), AOSD (MESH:D016706), hepatocellular injury (MESH:D056486), GD (MESH:D006111), inflammatory syndrome (MESH:D018746), hyperferritinemia (MESH:D000085583), arthralgia (MESH:D018771), thyroid dysfunction (MESH:D013959), immune dysregulation (OMIM:614878), hepatosplenomegaly (MESH:C535727), rash (MESH:D005076), autoimmune conditions (MESH:D001327), systemic autoimmune disorder (MESH:D020274), hyperthyroidism (MESH:D006980), leukocytosis (MESH:D007964)
- **Chemicals:** radioiodine (MESH:C000614965), carbimazole (MESH:D002231)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12831620/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12831620/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12831620/full.md

---
Source: https://tomesphere.com/paper/PMC12831620